pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-449b |
Genomic Coordinates | chr5: 55170646 - 55170742 |
Description | Homo sapiens miR-449b stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-449b-5p | ||||||||||||||||||
Sequence | 16| AGGCAGUGUAUUGUUAGCUGGC |37 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Microarray | DRVs in miRNA |
|
||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ARHGAP1 | ||||||||||||||||||||
Synonyms | CDC42GAP, RHOGAP, RHOGAP1, p50rhoGAP | ||||||||||||||||||||
Description | Rho GTPase activating protein 1 | ||||||||||||||||||||
Transcript | NM_004308 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ARHGAP1 | |||||||||||||||||||||
3'UTR of ARHGAP1 (miRNA target sites are highlighted) |
>ARHGAP1|NM_004308|3'UTR 1 ACCTGGCCCCTGCCCCACCAGCCCCTTCTCTGGTAGCCCGGGTTTGGACTCTTCCTCCTGGCATCAGGGGCCATGAAGCC 81 CCCTGGAGAGAGATGTTGGAGCCACCCATCAGGCATGCTCTCCCCCACCTCTGTCCAGCCCGCCTCACGGCCCTGGCGGC 161 CTCGCTGTTACCAGAAGACGTTTTTCTCTGCCTTACACTTCTCACTGCCTCTCTGGACACCGGGCTTTTGCTGGGCTCTC 241 CAGAGCTGGGCTTGGCTCTTCCAGCTGGAGAAGGACTGAGCCCCAGTAACCCCTTTCCTGCTTTTTCCTGCCTCTGTTTC 321 CCTAGCAAGTGTGGATGAATCAAATGACTGCCGGCTGGGCTGGTAGCAGGGGCCAGTCCTCCCCTCTTGATTGCTGGGAA 401 TGAGCAGCTGAGCTCTTTGGTGTGGACACCGCCCCAAGCTGAGGTGCCTCCCTATCTGGTAGGCTGCCCTGCTTTGCAGA 481 AGCCCCACTGCATGAAGGCCTGAGTGCAAGCACCCTTGCTCCTGTACTGCCCCCAGCAGCGCAGTCTGGGGTATTTCCCC 561 TGCTGAGGAGTGACAGGGCTGGAGACTGTGTCTGCTTTCTGCCTCCTCTTCCACACATCCTGGGTCAGCCTTTCCCAAGT 641 GATACTGCCCCTGGGGTGTCCTAACCCCTTGGTTGTGCAGGGACTGGTAGCTTGGATGACATGGCTCAGAGTCCCAGCAT 721 CCACTTGAAACCTCCCTCTCCACCTCCCCGCCCCCGAGAGCTACAGCGTGTGATGGAATCAGTGACCGGCCAGGTTAGCC 801 TCTCCCCTCTTGGCCTCCTTTCCCACACGGGCAGATCATCAGCCTTCATGTTCTTGTGGACCTGTCTGTTACGGAGTCAC 881 ACTGGCCCCTGCCCCAGCCAGAGGTGACTCAGTGCCTCAGGATCTTATGGCTCCTTCCTCCAGCTGGGGGACTCTTAAAG 961 GGGCTGGGGTAGAGACTAAGAGTGCCCGTAGGAGGGGCAGAGATTGTGCTGATAGGTCAGTCCAGATAGGTGGGTTCTAG 1041 CAATTTCCCCAGGGGATTAAGGGGCTCTAGGGCCACCTTTTTTTTTTTTTTTCTGAGATGGAGTCTCGCTCTGTCACCAG 1121 GCTGGAGTGCAGTGGCGCGATCTCGGCACACCTCCGCCTTCTGGGTTCAAGCAATTCTCCTGCCTCAGCCTCCTGAGTAG 1201 CTGGGACTATAGGTGCATGCCACCATGCCCAGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAG 1281 GATGGTCTCGATCTCCTGACCTCATGATCCACCCACCTCGGCCTCCCAAAGTGCTGGGATTCCAGGCGTGAGCCACTGCG 1361 CCCGGCCAGCCCTGTTGTCTTTCAAAGAACCTCGGCCCCAGTGATGGCTGATCTCACTCCCACTGTCTCGTAGAATTACA 1441 CTCCTTCCTGGGGATCCCTCTTCCTGCAGCCTTGTCCTTGGGGAGTACAGGGAAGTACCTGCAGTGACCCTGCCCCCATG 1521 ACCTTGGCCAGGCAGGATGATTCCAGAGCCCGTACTGTGGGGATCCTCACTGACCAGCCCAGCCCCATCCGCAAGCCAGG 1601 CTGGGCCTGGGCATAACTTCGCTGGGCTCTCCCAAGACCATCAGCAGTGCATCCAGCCCCCTGGGGCCTGGGCTGCTGCT 1681 GGTTCTTCATCAGTCCCTTGGTCTCTAGCCTCGGCCAGGGCTGCTCTGCTCTCCGCCCTCCTTTGTGTATCAAGTGTCGC 1761 TCACAGCCCCATTCACTGGGGAGCCTTTCGGATCTATTTGGTCTTTCTCATGTCCCCCACTGGTCTGTACCCCAGGGAGC 1841 GGGTGCTTGTACTGTGTGAATCCAGTGTTCACATTCACACTTAATGACTTCCTTGGCACCAATCATGTATTTCACCGTTT 1921 GCACTTTTTGTATTTCAATAAAAATGTTGATGCAAAACTGCTAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 392.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760597. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000311956.4 | 3UTR | UUUUUCUCUGCCUUACACUUCUCACUGCCUCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000311956.4 | 3UTR | UUUUCUCUGCCUUACACUUCUCACUGCCUCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000311956.4 | 3UTR | UUCUCUGCCUUACACUUCUCACUGCCUCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
109 hsa-miR-449b-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT006349 | SIRT1 | sirtuin 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT006350 | CCNE2 | cyclin E2 | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT006351 | MET | MET proto-oncogene, receptor tyrosine kinase | ![]() |
![]() |
2 | 1 | ||||||
MIRT006352 | GMNN | geminin, DNA replication inhibitor | ![]() |
![]() |
2 | 1 | ||||||
MIRT006353 | HDAC1 | histone deacetylase 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT016137 | CDK4 | cyclin dependent kinase 4 | ![]() |
1 | 1 | |||||||
MIRT016138 | CDC25A | cell division cycle 25A | ![]() |
![]() |
2 | 1 | ||||||
MIRT016139 | CDK6 | cyclin dependent kinase 6 | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT057740 | ZDHHC16 | zinc finger DHHC-type containing 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT078636 | FAM104A | family with sequence similarity 104 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT100407 | HSPA1B | heat shock protein family A (Hsp70) member 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT115552 | MAZ | MYC associated zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT130146 | TXNIP | thioredoxin interacting protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT142254 | DCTN5 | dynactin subunit 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT143724 | CCL22 | C-C motif chemokine ligand 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT168101 | E2F3 | E2F transcription factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT169809 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT183694 | MDM4 | MDM4, p53 regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT198922 | SMAD4 | SMAD family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT202950 | TSN | translin | ![]() |
![]() |
2 | 4 | ||||||
MIRT221565 | CBX3 | chromobox 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT253418 | EVI5L | ecotropic viral integration site 5 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT294759 | ZNF551 | zinc finger protein 551 | ![]() |
![]() |
2 | 4 | ||||||
MIRT307053 | TGFBR2 | transforming growth factor beta receptor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT331273 | TM9SF3 | transmembrane 9 superfamily member 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT372293 | UBXN2B | UBX domain protein 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT374317 | MBD6 | methyl-CpG binding domain protein 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445817 | DNAAF3 | dynein axonemal assembly factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447158 | MFSD8 | major facilitator superfamily domain containing 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447823 | CTIF | cap binding complex dependent translation initiation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT448798 | GMFB | glia maturation factor beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT451580 | HIRIP3 | HIRA interacting protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452679 | GPR156 | G protein-coupled receptor 156 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453158 | CNOT4 | CCR4-NOT transcription complex subunit 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT453634 | SLC4A2 | solute carrier family 4 member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455384 | PLA2G2D | phospholipase A2 group IID | ![]() |
![]() |
2 | 2 | ||||||
MIRT456958 | SPAM1 | sperm adhesion molecule 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462739 | EFNB1 | ephrin B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464321 | UST | uronyl 2-sulfotransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT465641 | TNRC18P2 | trinucleotide repeat containing 18 pseudogene 2 | ![]() |
![]() |
2 | 10 | ||||||
MIRT466748 | SYNGR2 | synaptogyrin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468345 | SF3B3 | splicing factor 3b subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469324 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474361 | KMT2D | lysine methyltransferase 2D | ![]() |
![]() |
2 | 2 | ||||||
MIRT475316 | IFNLR1 | interferon lambda receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477759 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477824 | DYRK3 | dual specificity tyrosine phosphorylation regulated kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478265 | DDX19B | DEAD-box helicase 19B | ![]() |
![]() |
2 | 2 | ||||||
MIRT481042 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT481289 | ATXN1L | ataxin 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT482730 | COPZ1 | coatomer protein complex subunit zeta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488780 | CYTH3 | cytohesin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489578 | SSBP2 | single stranded DNA binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489659 | SHMT1 | serine hydroxymethyltransferase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT490527 | KIAA1715 | lunapark, ER junction formation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT492949 | NEUROD2 | neuronal differentiation 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493154 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493845 | FOXN3 | forkhead box N3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT494743 | ARHGAP1 | Rho GTPase activating protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT496491 | MAST3 | microtubule associated serine/threonine kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT503312 | FICD | FIC domain containing | ![]() |
![]() |
2 | 4 | ||||||
MIRT503507 | ZNF623 | zinc finger protein 623 | ![]() |
![]() |
2 | 2 | ||||||
MIRT504182 | FAM127B | retrotransposon Gag like 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT505010 | ZNF644 | zinc finger protein 644 | ![]() |
![]() |
2 | 2 | ||||||
MIRT505352 | TMEM167A | transmembrane protein 167A | ![]() |
![]() |
2 | 2 | ||||||
MIRT505645 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT505710 | SESN2 | sestrin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT505777 | SATB2 | SATB homeobox 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT506208 | PHF19 | PHD finger protein 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT506251 | PEG10 | paternally expressed 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT507786 | CDKN1B | cyclin dependent kinase inhibitor 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT508005 | BCL2L13 | BCL2 like 13 | ![]() |
![]() |
2 | 4 | ||||||
MIRT508857 | ZRSR1 | zinc finger CCCH-type, RNA binding motif and serine/arginine rich 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT510546 | XBP1P1 | X-box binding protein 1 pseudogene 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT511892 | GAS1 | growth arrest specific 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT512907 | UBL4A | ubiquitin like 4A | ![]() |
![]() |
2 | 2 | ||||||
MIRT513600 | VPS37B | VPS37B, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT521241 | SAR1A | secretion associated Ras related GTPase 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT521321 | RRAGD | Ras related GTP binding D | ![]() |
![]() |
2 | 4 | ||||||
MIRT525281 | C18orf32 | chromosome 18 open reading frame 32 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528650 | RWDD2A | RWD domain containing 2A | ![]() |
![]() |
2 | 4 | ||||||
MIRT535101 | PODXL | podocalyxin like | ![]() |
![]() |
2 | 2 | ||||||
MIRT547752 | KBTBD6 | kelch repeat and BTB domain containing 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT547865 | HSPA13 | heat shock protein family A (Hsp70) member 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT549170 | BMP3 | bone morphogenetic protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT550115 | SLC35G2 | solute carrier family 35 member G2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT556097 | MOAP1 | modulator of apoptosis 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557172 | HOXA13 | homeobox A13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557422 | GXYLT2 | glucoside xylosyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557931 | FAM73A | mitoguardin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568804 | VPS37D | VPS37D, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT571326 | TPCN2 | two pore segment channel 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572598 | PAPLN | papilin, proteoglycan like sulfated glycoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT573437 | APOPT1 | apoptogenic 1, mitochondrial | ![]() |
![]() |
2 | 2 | ||||||
MIRT574092 | VASN | vasorin | ![]() |
![]() |
2 | 2 | ||||||
MIRT608688 | VAV3 | vav guanine nucleotide exchange factor 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT608800 | ITGA11 | integrin subunit alpha 11 | ![]() |
![]() |
2 | 4 | ||||||
MIRT610332 | SSX5 | SSX family member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT613158 | DDA1 | DET1 and DDB1 associated 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625407 | CPEB3 | cytoplasmic polyadenylation element binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636603 | CLIC5 | chloride intracellular channel 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638573 | IER5 | immediate early response 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639686 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT677979 | ITGB3 | integrin subunit beta 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT685217 | POTED | POTE ankyrin domain family member D | ![]() |
![]() |
2 | 2 | ||||||
MIRT702570 | JARID2 | jumonji and AT-rich interaction domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706259 | MKLN1 | muskelin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT734675 | HMGB1 | high mobility group box 1 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT736369 | HSPA1A | heat shock protein family A (Hsp70) member 1A | ![]() |
1 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|